Research project
Niraparib Efficacy in Relapsed MesOthelioma (NERO). A Randomised Phase II trial of Niraparib versus active symptom control in Patients with Relapsed Malignant Mesothelioma
-
Lead researchers:
-
Research funder:British Lung Foundation
-
Status:Not active
